Literature DB >> 15029196

Conformational variations in an infectious protein determine prion strain differences.

Motomasa Tanaka1, Peter Chien, Nariman Naber, Roger Cooke, Jonathan S Weissman.   

Abstract

A remarkable feature of prion biology is the strain phenomenon wherein prion particles apparently composed of the same protein lead to phenotypically distinct transmissible states. To reconcile the existence of strains with the 'protein-only' hypothesis of prion transmission, it has been proposed that a single protein can misfold into multiple distinct infectious forms, one for each different strain. Several studies have found correlations between strain phenotypes and conformations of prion particles; however, whether such differences cause or are simply a secondary manifestation of prion strains remains unclear, largely due to the difficulty of creating infectious material from pure protein. Here we report a high-efficiency protocol for infecting yeast with the [PSI+] prion using amyloids composed of a recombinant Sup35 fragment (Sup-NM). Using thermal stability and electron paramagnetic resonance spectroscopy, we demonstrate that Sup-NM amyloids formed at different temperatures adopt distinct, stably propagating conformations. Infection of yeast with these different amyloid conformations leads to different [PSI+] strains. These results establish that Sup-NM adopts an infectious conformation before entering the cell--fulfilling a key prediction of the prion hypothesis--and directly demonstrate that differences in the conformation of the infectious protein determine prion strain variation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029196     DOI: 10.1038/nature02392

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  371 in total

1.  Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.

Authors:  Ayisha Siddiqua; Martin Margittai
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Amyloid of the Candida albicans Ure2p prion domain is infectious and has an in-register parallel β-sheet structure.

Authors:  Abbi Engel; Frank Shewmaker; Herman K Edskes; Fred Dyda; Reed B Wickner
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

3.  Concern about mad cow disease: end of the beginning, or beginning of the end?

Authors:  Herbert Budka
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

Review 4.  Modulation and elimination of yeast prions by protein chaperones and co-chaperones.

Authors:  Michael Reidy; Daniel C Masison
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

Review 5.  Yeast prions assembly and propagation: contributions of the prion and non-prion moieties and the nature of assemblies.

Authors:  Mehdi Kabani; Ronald Melki
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

6.  The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies.

Authors:  I-Fan Wang; Hsiang-Yu Chang; Shin-Chen Hou; Gunn-Guang Liou; Tzong-Der Way; C-K James Shen
Journal:  Nat Commun       Date:  2012-04-03       Impact factor: 14.919

Review 7.  More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change.

Authors:  Anupam K Chakravarty; Daniel F Jarosz
Journal:  J Mol Biol       Date:  2018-07-19       Impact factor: 5.469

Review 8.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

9.  Organizing biochemistry in space and time using prion-like self-assembly.

Authors:  Christopher M Jakobson; Daniel F Jarosz
Journal:  Curr Opin Syst Biol       Date:  2017-12-06

10.  The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.

Authors:  John A Pezza; Sara X Langseth; Rochele Raupp Yamamoto; Stephen M Doris; Samuel P Ulin; Arthur R Salomon; Tricia R Serio
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.